Literature DB >> 1877453

Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus.

D S Blondheim1, L E Jacobs, M N Kotler, G A Costacurta, W R Parry.   

Abstract

Ninety-one patients with dilated cardiomyopathy were studied by two-dimensional, pulsed, and color Doppler echocardiography (1) to detect and quantify mitral regurgitation (MR), (2) to record apical flow velocities in systole and diastole, and (3) to detect the presence of left ventricular thrombi. MR was detected in 57% of the patients and thrombi were present in 40%, but the occurrence of both MR and thrombus was rare (8%). Apical flow velocity was significantly higher throughout the cardiac cycle in the group with MR (diastole 15 +/- 7 vs 9 +/- 7 cm/sec; systole 29 +/- 12 vs 16 +/- 13 cm/sec; p less than 0.001 for both), accounting for the rarity of thrombi in this group. Follow-up data on 89% of the patients showed markedly decreased survival in the group with MR (22% vs 60% at 32 +/- 6 months, p less than 0.005), and this was evident even in patients with mild MR. Thus although MR is a noninvasively obtainable marker of a large subgroup of patients with dilated cardiomyopathy "protected" from left ventricular thrombus formation, it is a sensitive marker of decreased survival.

Entities:  

Mesh:

Year:  1991        PMID: 1877453     DOI: 10.1016/0002-8703(91)90523-k

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  33 in total

Review 1.  Surgical alternatives to transplantation and assist devices in the treatment of heart failure.

Authors:  J J DeRose; M C Oz
Journal:  Curr Cardiol Rep       Date:  2000-11       Impact factor: 2.931

Review 2.  [Coronary sinus devices for treatment of functional mitral valve regurgitation. Solution or dead end?].

Authors:  H Degen; T Schneider; J Wilke; M Haude
Journal:  Herz       Date:  2013-08       Impact factor: 1.443

Review 3.  Ischemic and functional mitral regurgitation in heart failure: natural history and treatment.

Authors:  Mina M Benjamin; Robert L Smith; Paul A Grayburn
Journal:  Curr Cardiol Rep       Date:  2014-08       Impact factor: 2.931

4.  Exercise echocardiography in the evaluation of severity of functional mitral regurgitation in patients with heart failure.

Authors:  Yumiko Kobayashi; Yasushi Sakata; Yasuharu Takeda; Toshiaki Mano; Jun Yokogawa; Goro Matsumiya; Yoshiki Sawa; Satoshi Nakatani; Kazuhiro Yamamoto; Issei Komuro
Journal:  J Echocardiogr       Date:  2010-02-25

5.  Prognostic significance of residual functional mitral regurgitation in hospitalized heart failure patients with chronic atrial fibrillation and preserved ejection fraction after medical therapies.

Authors:  Kazato Ito; Yukio Abe; Hiroyuki Watanabe; Yoshihisa Shimada; Kentaro Shibayama; Hiroki Oe; Eiichi Hyodo; Chinami Miyazaki; Yosuke Takahashi; Toshihiko Shibata; Hiroshi Ito
Journal:  J Echocardiogr       Date:  2018-12-19

6.  Thromboembolic risk in the patient with heart failure.

Authors:  Liviu Klein; John B O'connell
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-08

Review 7.  Nontransplant surgical options for congestive heart failure.

Authors:  J Ferrão de Oliveira; Manuel J Antunes
Journal:  Curr Cardiol Rep       Date:  2004-05       Impact factor: 2.931

8.  Aortic stiffness: an old concept for new insights into the pathophysiology of functional mitral regurgitation.

Authors:  Andrea Rossi; Stefano Bonapace; Mariantonietta Cicoira; Luca Conte; Anna Anselmi; Corrado Vassanelli
Journal:  Heart Vessels       Date:  2012-10-13       Impact factor: 2.037

9.  The effects of mitral regurgitation alone are sufficient for leaflet remodeling.

Authors:  Elizabeth H Stephens; Tom C Nguyen; Akinobu Itoh; Neil B Ingels; D Craig Miller; K Jane Grande-Allen
Journal:  Circulation       Date:  2008-09-30       Impact factor: 29.690

10.  Surgery of secondary mitral insufficiency in patients with impaired left ventricular function.

Authors:  Andreas Rukosujew; Stefan Klotz; Henryk Welp; Christian Bruch; Farshad Ghezelbash; Christoph Schmidt; Raluca Weber; Andreas Hoffmeier; Jürgen Sindermann; Hans H Scheld
Journal:  J Cardiothorac Surg       Date:  2009-07-17       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.